GB0206723D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB0206723D0 GB0206723D0 GBGB0206723.9A GB0206723A GB0206723D0 GB 0206723 D0 GB0206723 D0 GB 0206723D0 GB 0206723 A GB0206723 A GB 0206723A GB 0206723 D0 GB0206723 D0 GB 0206723D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0206723.9A GB0206723D0 (en) | 2002-03-21 | 2002-03-21 | Novel compounds |
AU2003219100A AU2003219100A1 (en) | 2002-03-21 | 2003-03-20 | Pyrazolopyridazine derivatives, process for preparation and use for the inhibition of gsk-3 |
PCT/EP2003/003171 WO2003080616A1 (en) | 2002-03-21 | 2003-03-20 | Pyrazolopyridazine derivatives, process for preparation and use for the inhibition of gsk-3 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0206723.9A GB0206723D0 (en) | 2002-03-21 | 2002-03-21 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0206723D0 true GB0206723D0 (en) | 2002-05-01 |
Family
ID=9933463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0206723.9A Ceased GB0206723D0 (en) | 2002-03-21 | 2002-03-21 | Novel compounds |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003219100A1 (en) |
GB (1) | GB0206723D0 (en) |
WO (1) | WO2003080616A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1435957B1 (en) * | 2001-04-30 | 2009-06-17 | Vertex Pharmaceuticals Incorporated | Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes |
US7582630B2 (en) * | 2002-10-15 | 2009-09-01 | Smithkline Beecham Corporation | Pyradazine compounds as GSK-3 inhibitors |
US7601718B2 (en) | 2003-02-06 | 2009-10-13 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of protein kinases |
EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
US7985756B2 (en) | 2005-10-21 | 2011-07-26 | Braincells Inc. | Modulation of neurogenesis by PDE inhibition |
US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
JP2009536669A (en) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | Neurogenesis by angiotensin regulation |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
AU2007324696B2 (en) * | 2006-11-24 | 2012-10-04 | Ac Immune S.A. | N- (methyl) -1H- pyrazol- 3 -amine, N- (methyl) -pyridin-2-amine and N- (methyl) -thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. Alzheimer's |
CA2683046A1 (en) * | 2007-04-09 | 2008-10-16 | F. Hoffmann-La Roche Ag | Non-nucleoside reverse transcriptase inhibitors |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
EP2789615B1 (en) | 2009-08-11 | 2017-05-03 | Bristol-Myers Squibb Company | Azaindazoles as Btk kinase modulators and use thereof |
EP2311823A1 (en) | 2009-10-15 | 2011-04-20 | AC Immune S.A. | 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases |
EP2463289A1 (en) * | 2010-11-26 | 2012-06-13 | Almirall, S.A. | Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors |
ES2625534T3 (en) * | 2011-04-25 | 2017-07-19 | Usher Iii Initiative | Pyrazolopyridazines and methods for the treatment of degenerative diseases of the retina and hearing loss associated with Usher syndrome |
US8765762B2 (en) | 2012-10-25 | 2014-07-01 | Usher III, Initiative, Inc. | Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndrome |
PL2911671T3 (en) * | 2012-10-25 | 2018-11-30 | Usher Iii Initiative, Inc. | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
US9227976B2 (en) | 2012-10-25 | 2016-01-05 | Usher Iii Initiative, Inc. | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
WO2017045955A1 (en) * | 2015-09-14 | 2017-03-23 | Basf Se | Heterobicyclic compounds |
WO2022011091A1 (en) * | 2020-07-09 | 2022-01-13 | Usher Iii Initiative, Inc. | Treatment of cancer, inflammatory diseases and autoimmune diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002528543A (en) * | 1998-10-30 | 2002-09-03 | メルク エンド カムパニー インコーポレーテッド | Thrombin inhibitor |
-
2002
- 2002-03-21 GB GBGB0206723.9A patent/GB0206723D0/en not_active Ceased
-
2003
- 2003-03-20 WO PCT/EP2003/003171 patent/WO2003080616A1/en not_active Application Discontinuation
- 2003-03-20 AU AU2003219100A patent/AU2003219100A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003219100A1 (en) | 2003-10-08 |
WO2003080616A1 (en) | 2003-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0202216D0 (en) | Novel compounds | |
GB0205256D0 (en) | Novel compounds | |
GB0202679D0 (en) | Novel compounds | |
GB0206723D0 (en) | Novel compounds | |
GB0207249D0 (en) | Novel compounds | |
GB0207246D0 (en) | Novel compounds | |
GB0203299D0 (en) | Novel compounds | |
GB0226822D0 (en) | Novel compounds | |
GB0200025D0 (en) | Novel compounds | |
GB0204252D0 (en) | Novel compounds | |
GB0202219D0 (en) | Novel compounds | |
GB0206716D0 (en) | Novel compounds | |
GB0203901D0 (en) | Novel compounds | |
GB0203680D0 (en) | Novel compounds | |
GB0203677D0 (en) | Novel compounds | |
GB0203673D0 (en) | Novel compounds | |
GB0203437D0 (en) | Novel compounds | |
GB0203369D0 (en) | Novel compounds | |
GB0203363D0 (en) | Novel compounds | |
GB0203301D0 (en) | Novel compounds | |
GB0203300D0 (en) | Novel compounds | |
GB0202637D0 (en) | Novel compounds | |
GB0202636D0 (en) | Novel compounds | |
GB0202442D0 (en) | Novel compounds | |
GB0204255D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |